Cited by 198Stroke Rehabilitation and RecoveryAcute Ischemic Stroke ManagementNeurological Disorders and Treatments

Functional Recovery in Aged and Young Rats After Embolic Stroke: Treatment With a Phosphodiesterase Type 5 Inhibitor

Zhang, Li, Zhang, Rui Lan, Wang, Ying, Zhang, Chunling, Zhang, Zheng Gang, Meng, He, Chopp, Michael·2005·Stroke

Abstract

Background and Purpose— Advanced age is associated with a decrease in brain plasticity compared with the young adult. Sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor promotes brain plasticity and improves functional outcome after stroke in the young animal. Here, we test the hypothesis that sildenafil provides restorative therapeutic benefit to the aged animal. Methods— Male Wistar rats (aged, 18-month old; young, 3-month old) were subjected to embolic stroke. Saline or sildenafil was administered daily at a dose of 2 mg/kg orally or 10 mg/kg subcutaneously for 7 consecutive days starting 24 hour after stroke onset. Results— Aged rats exhibited significant impairment of functional recovery and reductions of vascular density, and endothelial cell proliferation compared with young rats. Aged rats treated with sildenafil at a dose of 10 mg/kg but not 2 mg/kg, showed significant improvements of functional recovery and concomitant increases in cortical cyclic guanosine 3′,5′-cyclic monophosphate (cGMP) level, vascular density, endothelial cell proliferation, and synaptogenesis compared with aged rats treated with saline. In young rats, treatment with sildenafil at a dose of 2 or 10 mg/kg significantly enhanced functional recovery and amplified brain plasticity compared with young rats treated with saline. Conclusion— Age is associated with reduction of angiogenesis, and poor neurological functional recovery after stroke. However, treatment of aged stroke rats with sildenafil improves functional recovery that is likely fostered by enhancement of angiogenesis and synaptogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.str.0000158923.19956.73

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In aged rats with ischaemia, treatment with anti-NogoA antibodies, pharmacological compounds, or bone-marrow-derived stromal cells improved neurological recovery and was linked to preservation of ipsilateral pyramidal tract axons and enhanced contralateral pyramidal tract sprouting.

    “Improved neurological recovery associated with preservation of pyramidal tract axons ipsilateral to the stroke and enhanced pyramidal tract sprouting contralateral to the stroke was identified in 25-month-old or 12-month-old rats with ischaemia treated with neutralising anti-NogoA antibodies,17 pharmacological compounds, 76 or bone-marrow-derived stromal cells.26”
  • Aged rats can respond to plasticity-promoting treatments, though age may influence some processes that neurorestorative interventions target.

    “Aged rats respond to plasticity-promoting therapies, but age might have an effect on some of the processes targeted by neurorestorative interventions.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, L., Zhang, R. L., Wang, Y., Zhang, C., Zhang, Z. G., Meng, H., & Chopp, M.
Affiliations
Henry Ford Health (US)
Venue
Stroke
Published
2005-04
Volume
36
Issue
4
Pages
847-852
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2002956393
Cited by
198
References
25
Citations by year
2026: 1 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 7 · 2016: 4 · 2015: 12 · 2014: 16 · 2013: 16 · 2012: 24
FWCI
15.91
Type
journal article
Language
en
Open access
closed
Locations
  • Stroke (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL064766, R01HL64766)
  • National Institute of Neurological Disorders and Stroke (P01NS23393, P01NS023393, P01NS42345, R01 NS 38292, P01NS042345, R01NS038292)
Topics
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
Keywords
embolic stroke, sildenafil, aging, functional recovery, neuroplasticity, angiogenesis, endothelial cell proliferation, synaptogenesis, cyclic GMP, vessel density, phosphodiesterase-5 inhibitors
MeSH terms
Sildenafil Citrate, Aging, Animals, Bromodeoxyuridine, Disease Models, Animal, Endothelium, Vascular, Cyclic GMP, Immunohistochemistry, Male, Neovascularization, Pathologic, Neuronal Plasticity, Phosphodiesterase Inhibitors, Phosphoric Diester Hydrolases, Piperazines, Purines, Sodium Chloride, Sulfones, Synapses, Time Factors, 3',5'-Cyclic-GMP Phosphodiesterases, Synaptophysin, Treatment Outcome, Rats, Wistar, Stroke, Cell Proliferation, Rats, Cyclic Nucleotide Phosphodiesterases, Type 5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review